Content about Eli Lilly and Company

June 19, 2013
Three new Takeda diabetes drugs become available

Three new drugs for Type 2 diabetes made by Takeda Pharmaceutical have become available in pharmacies, the company said.

June 10, 2013
Avandia could get a second chance, following FDA panel vote

A 26-member joint panel comprising the Food and Drug Administration's Endocrinologic and Metabolic Drugs and Drug Safety and Risk Management advisory committees voted to support modifying or removing the risk evaluation and mitigation strategy protocol for GlaxoSmithKline's Type 2 diabetes drug Avandia (rosiglitazone).

Historically, the FDA has followed advisory committee votes when making a decision on the marketing of a drug even though it is not bound by them, but assuming the agency follows the panel's advice, it could mean a lot for the controversial drug and the way it's dispensed. But even if Avandia winds up on retail pharmacy shelves again, it faces a very different landscape from its heyday.

June 7, 2013
Avandia could remain available following FDA advisory committee vote

A joint Food and Drug Administration expert panel voted to recommend keeping a controversial GlaxoSmithKline diabetes drug available for certain patients, GSK said.

April 12, 2013
Celgene head elected as PhRMA chairman

Celgene Corp. chairman and CEO Robert Hugin has been elected as chairman of a pharmaceutical industry trade group.

April 12, 2013
FDA investigation finds widespread problems at compounding pharmacies

An inspection of more than two-dozen compounding pharmacies by Food and Drug Administration officials has found widespread problems with sanitation and sterilization practices, FDA commissioner Margaret Hamburg wrote in a blog post on the agency's website Thursday.

April 5, 2013
Novo Nordisk launches Race with Insulin contest with Charlie Kimball as spokesman

Novo Nordisk has launched a diabetes awareness sweepstakes in which the winners get a free trip to the 2013 IndyCar finale, the Danish drug maker said.

March 25, 2013
Lilly, BI apply for diabetes drug approval

Boehringer Ingelheim and Eli Lilly are seeking regulatory approval for an experimental drug to treat Type 2 diabetes, the companies said.

March 22, 2013
Genzyme drug shows improvement in MS patients

Disease relapse rates and worsening of disability were low among patients taking a drug made by Genzyme for multiple sclerosis, the company said.

February 19, 2013
FDA approves Aurobindo diabetes drug

The Food and Drug Administration has approved a generic diabetes drug made by Aurobindo Pharma, the drug maker said.

February 19, 2013
Mylan, Biocon enter deal on generic analog insulins

Mylan and Biocon have a deal to develop and sell generic insulin-analog products for diabetes, Mylan said.

February 11, 2013
FDA turns down two Novo Nordisk insulin products

The Food and Drug Administration declined to approve two insulin products made by Danish drug maker Novo Nordisk, the company said Sunday.

February 8, 2013
FDA approves generic diabetes drug

The Food and Drug Administration has approved a generic diabetes drug made by Macleods Pharma, according to agency records.

January 29, 2013
Eli Lilly reports 1% Q4 decline from Zyprexa patent expiration

Eli Lilly and Company reported that its fourth quarter revenue for the period ended Dec. 31 declined 1% to $6 billion because of its Zyprexa patent expiration. Full-year 2012 revenue declined 7% to $22.6 billion.

January 28, 2013
FDA approves three new drugs for Type 2 diabetes

The Food and Drug Administration has approved three new drugs for Type 2 diabetes made by Takeda, the agency said.

December 6, 2012
FDA grants orphan drug designation to Biodel drug for rare insulin disease

The Food and Drug Administration has given special designation to a treatment made by Biodel for patients with congenital hyperinsulinism, a rare disorder that affects children.

November 9, 2012
FDA panel recommends approval for two Novo Nordisk insulin products

A Food and Drug Administration panel has voted to support two experimental insulin treatments made by Novo Nordisk, the Danish drug maker said Thursday.

November 2, 2012
Lilly to expand Indianapolis insulin factory

Eli Lilly is spending $140 million to expand its insulin manufacturing plant in Indianapolis, the drug maker said.

October 29, 2012
Watson launches generic version of Actos

The Food and Drug Administration has approved a Type 2 diabetes drug made by Watson Pharmaceuticals, the company said, following a federal court's order for the agency to approve the drug.

October 24, 2012
Mylan hopes to stop Watson launch of diabetes drug

Mylan is challenging a federal court decision ordering the Food and Drug Administration to allow Watson Pharmaceuticals to launch a generic diabetes drug, Mylan said.

October 23, 2012
Federal court orders FDA to allow Watson diabetes drug launch

A federal court has ordered the Food and Drug Administration to approve a generic diabetes drug made by Watson Pharmaceuticals, the drug maker said.

September 14, 2012
Lilly, BI launch diabetes-education program

Drug makers Boehringer Ingelheim and Eli Lilly have created a new online educational program for people with Type 2 diabetes.

August 29, 2012
Lilly ceases clinical research of pomaglumetad methionil as schizophrenia treatment

Eli Lilly has ceased ongoing clinical studies of an investigational treatment for schizophrenia.

August 27, 2012
FDA approves generic version of Actos

The Food and Drug Administration has approved the first generic version of a diabetes drug made by Takeda, the agency said Friday.

August 17, 2012
Ranbaxy launches authorized generic diabetes drug

Ranbaxy Labs has launched an authorized generic version of a diabetes drug made by Takeda Pharmaceutical, Ranbaxy said Friday.

August 17, 2012
Teva launches authorized generic Actos

Teva Pharmaceutical Industries announced the launch of an authorized generic of a Type 2 diabetes drug.

© 2013 Drug Store News. All Rights Reserved.